In an important academic milestone reflecting growing international recognition, Dr. Pragya Baghel, an accomplished pharmaceutical researcher and Associate Professor, has surpassed 269 Google Scholar citations, demonstrating the increasing global influence of her research in nanomedicine, advanced drug delivery systems, pharmaceutical formulation development, and novel drug delivery technologies.
According to her latest Google Scholar profile, Dr. Pragya Baghel has accumulated 269 total citations, including an impressive 216 citations since 2021, with an h-index of 9 and an i10-index of 5. These bibliometric indicators underscore the sustained scientific relevance of her scholarly contributions and the expanding impact of her research on pharmaceutical scientists, academicians, and healthcare researchers worldwide.
Emerging Leader in Nanomedicine and Pharmaceutical Formulation Research
Over the past decade, Dr. Pragya Baghel has contributed significantly to the advancement of pharmaceutical sciences through innovative research focusing on nanomedicine, advanced drug delivery systems, bioavailability enhancement, natural polymer-based formulations, and pharmaceutical technology. Her work integrates modern formulation strategies with innovative carrier systems to improve therapeutic performance, enhance patient compliance, and address challenges associated with conventional drug delivery.
Her research reflects the growing trend toward developing targeted, efficient, and patient-centric pharmaceutical dosage forms capable of improving clinical outcomes across multiple therapeutic areas.
Highly Cited Publications Reflecting Scientific Impact
Among her most influential scholarly contributions is the review article "Current Promising Treatment Strategy for Glioblastoma Multiforme: A Review," which has received more than 120 citations. The publication provides a comprehensive overview of emerging therapeutic strategies for glioblastoma multiforme, one of the most aggressive forms of brain cancer, and continues to serve as an important reference for researchers in oncology and pharmaceutical sciences.
Another widely cited publication, "Amelioration of Lipophilic Compounds in Regards to Bioavailability as Self-Emulsifying Drug Delivery System (SEDDS)," has accumulated nearly 50 citations, highlighting the growing importance of lipid-based drug delivery systems in improving the oral absorption of poorly water-soluble drugs.
Her review "Fast Dissolving Drug Delivery Systems: A Brief Review" has also gained considerable academic recognition by summarizing advances in rapidly disintegrating pharmaceutical dosage forms designed to enhance patient compliance and therapeutic effectiveness.
Additional research contributions on pulsatile drug delivery systems, gastroretentive drug delivery, self-microemulsifying drug delivery systems (SMEDDS), natural mucilage-based formulations, and drug solubility enhancement further demonstrate her multidisciplinary expertise in pharmaceutical formulation science.
Advancing Drug Delivery Through Innovative Pharmaceutical Technologies
Dr. Pragya Baghel's research portfolio encompasses several emerging domains of pharmaceutical sciences, including:
- Nanomedicine
- Advanced Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems (SEDDS)
- Self-Microemulsifying Drug Delivery Systems (SMEDDS)
- Gastroretentive Drug Delivery
- Fast Dissolving Drug Delivery Systems
- Pulsatile Drug Delivery
- Natural Polymer-Based Formulations
- Solubility Enhancement Technologies
- Pharmaceutical Nanotechnology
- Tissue Engineering Applications
- Herbal and Natural Excipient-Based Drug Delivery
Her research has contributed to improving the understanding of advanced formulation technologies capable of enhancing drug bioavailability, therapeutic efficacy, and targeted delivery while supporting the development of safer and more efficient pharmaceutical products.
Strong Scientific Collaborations
Throughout her research career, Dr. Pragya Baghel has collaborated with several distinguished pharmaceutical scientists, including Prof. (Dr.) Ananta Choudhury, Dr. Sanjib Bahadur, and Dr. Monika Bhairam, among other researchers. These collaborative efforts have resulted in numerous peer-reviewed publications in respected national and international journals, contributing significantly to pharmaceutical technology, formulation science, nanomedicine, and advanced drug delivery research.
Her collaborative approach has strengthened interdisciplinary pharmaceutical research and facilitated the development of innovative therapeutic strategies addressing contemporary healthcare challenges.
Contributing to the Future of Pharmaceutical Sciences
Beyond her publication record, Dr. Pragya Baghel continues to contribute to pharmaceutical education and scientific advancement through research focused on formulation optimization, novel carrier systems, and nanotechnology-based therapeutics. Her recent work also extends into tissue engineering, drug solubility enhancement, and ethnopharmacological research, illustrating the expanding scope of her scientific interests.
As pharmaceutical sciences increasingly embrace precision medicine and nanotechnology, her research provides valuable insights that support the development of next-generation drug delivery platforms capable of improving treatment outcomes and patient quality of life.
A Milestone Reflecting Growing International Recognition
Crossing the 250-citation mark represents a significant indicator of the quality, consistency, and scholarly influence of Dr. Pragya Baghel's research contributions. The continued citation of her publications by researchers across the world reflects their scientific relevance and enduring value in advancing pharmaceutical technology and innovative drug delivery science.
Her achievements exemplify the growing contribution of emerging Indian researchers to global pharmaceutical innovation and reinforce the importance of interdisciplinary research in addressing complex healthcare challenges through evidence-based scientific solutions.
The Editorial Team extends its sincere congratulations to Dr. Pragya Baghel on achieving this distinguished academic milestone. Her dedication to research excellence, pharmaceutical innovation, and academic scholarship continues to inspire young researchers while strengthening India's contribution to the global advancement of pharmaceutical sciences and nanomedicine.
.png)
0 Comments
Your comments add value to the news!!